JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hertzberg, M. S.
Right arrow Articles by Furie, B. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hertzberg, M. S.
Right arrow Articles by Furie, B. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 267, Issue 21, 14759-14766, 07, 1992

Construction, expression, and characterization of a chimera of factor IX and factor X. The role of the second epidermal growth factor domain and serine protease domain in factor Va binding

MS Hertzberg, O Ben-Tal, B Furie and BC Furie
Center for Hemostasis and Thrombosis Research, Tufts University School of Medicine, Boston, Massachusetts 02111.

The prothrombinase complex, which catalyzes the conversion of prothrombin to thrombin, consists of activated Factor X, Factor Va, a membrane surface and Ca2+. To examine the structures that support Factor Va binding to Factor X, we used in vitro mutagenesis to construct a chimeric molecule that includes regions of Factor IX and Factor X. This chimera (IXGla,E1XE2,SP) was prepared from cDNA encoding the second epidermal growth factor (EGF) and serine protease domains of Factor X linked downstream from the cDNA encoding the signal peptide, propeptide, Gla domain, and first EGF domain of Factor IX. The cDNAs encoding the Factor IX/X chimera and wild-type Factor X were each expressed in Chinese hamster ovary cells and the secreted proteins purified by affinity chromatography using polyclonal anti-Factor X antibodies. The chimera migrated as a single major band corresponding to a molecular weight of 68,000. By Western blotting, the chimeric protein stained with both polyclonal anti-Factor X and anti-Factor IX antibodies. gamma-Carboxyglutamic acid analysis demonstrated near complete carboxylation of both the wild-type Factor X and the Factor IX/X chimera. Compared with Factor X, the rate of zymogen activation of the Factor IX/X chimera was about 50% that of Factor X when activated by Factor IXa, Factor VIIIa, phospholipid, and Ca2+. The enzyme form of the Factor IX/X chimera, activated Factor IX/X, generated using the coagulant protein of Russell's viper venom, expressed full amidolytic activity compared with Factor Xa. The activated Factor IX/X chimera had about 14% of the activity of Factor Xa when employed in a prothrombinase assay; this activity reached 100% with increasing concentrations of Factor Va. A binding assay was employed to test the ability of the active site-inactivated Factor IX/Xa chimera to inhibit the binding of Factor Xa to the Factor Va-phospholipid complex, thus inhibiting the activation of prothrombin to thrombin. In this assay the active site-inactivated form of the chimera competed with Factor Xa completely but with decreased affinity for the Factor Va-phospholipid complex. These data indicate that the second EGF domain and the serine protease domain of Factor Xa are sufficient to interact with Factor Va. The Factor IX/X chimera is a good substrate for the tenase complex; the defective enzymatic activity of the activated Factor IX/X chimera can be accounted for by its decreased affinity for Factor Va relative to Factor Xa.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
F. S. Kittur, C. Manithody, and A. R. Rezaie
Role of the N-terminal Epidermal Growth Factor-like Domain of Factor X/Xa
J. Biol. Chem., June 4, 2004; 279(23): 24189 - 24196.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Yegneswaran, R. M. Mesters, and J. H. Griffin
Identification of Distinct Sequences in Human Blood Coagulation Factor Xa and Prothrombin Essential for Substrate and Cofactor Recognition in the Prothrombinase Complex
J. Biol. Chem., August 29, 2003; 278(35): 33312 - 33318.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Yang, C. Manithody, S. T. Olson, and A. R. Rezaie
Contribution of Basic Residues of the Autolysis Loop to the Substrate and Inhibitor Specificity of Factor IXa
J. Biol. Chem., June 27, 2003; 278(27): 25032 - 25038.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Shikamoto, T. Morita, Z. Fujimoto, and H. Mizuno
Crystal Structure of Mg2+- and Ca2+-bound Gla Domain of Factor IX Complexed with Binding Protein
J. Biol. Chem., June 20, 2003; 278(26): 24090 - 24094.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Thiec, G. Cherel, and O. D. Christophe
Role of the Gla and First Epidermal Growth Factor-like Domains of Factor X in the Prothrombinase and Tissue Factor-Factor VIIa Complexes
J. Biol. Chem., March 14, 2003; 278(12): 10393 - 10399.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. S. Joseph, M. C.M. Chung, K. Jeyaseelan, and R. M. Kini
Amino Acid Sequence of Trocarin, a Prothrombin Activator From Tropidechis carinatus Venom: Its Structural Similarity to Coagulation Factor Xa
Blood, July 15, 1999; 94(2): 621 - 631.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. S. Hertzberg, S. L. Facey, and P. J. Hogg
An Arg/Ser Substitution in the Second Epidermal Growth Factor-Like Module of Factor IX Introduces an O-Linked Carbohydrate and Markedly Impairs Activation by Factor XIa and Factor VIIa/Tissue Factor and Catalytic Efficiency of Factor IXa
Blood, July 1, 1999; 94(1): 156 - 163.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. C. Furie, J. V. Ratcliffe, J. Tward, M. J. Jorgensen, L. S. Blaszkowsky, D. DiMichele, and B. Furie
The gamma -Carboxylation Recognition Site Is Sufficient to Direct Vitamin K-dependent Carboxylation on an Adjacent Glutamate-rich Region of Thrombin in a Propeptide-Thrombin Chimera
J. Biol. Chem., November 7, 1997; 272(45): 28258 - 28262.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. M. Regan, J. S. Mollica, A. R. Rezaie, and C. T. Esmon
The Interaction between the Endothelial Cell Protein C Receptor and Protein C Is Dictated by the gamma -Carboxyglutamic Acid Domain of Protein C
J. Biol. Chem., October 17, 1997; 272(42): 26279 - 26284.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. K. Sabharwal, K. Padmanabhan, A. Tulinsky, A. Mathur, J. Gorka, and S. P. Bajaj
Interaction of Calcium with Native and Decarboxylated Human Factor X.. EFFECT OF PROTEOLYSIS IN THE AUTOLYSIS LOOP ON CATALYTIC EFFICIENCY AND FACTOR Va BINDING
J. Biol. Chem., August 29, 1997; 272(35): 22037 - 22045.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Baugh and S. Krishnaswamy
Role of the Activation Peptide Domain in Human Factor X Activation by the Extrinsic Xase Complex
J. Biol. Chem., July 5, 1996; 271(27): 16126 - 16134.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. J. Kotkow, S. R. Deitcher, B. Furie, and B. C. Furie
The Second Kringle Domain of Prothrombin Promotes Factor Va- mediated Prothrombin Activation by Prothrombinase
J. Biol. Chem., March 3, 1995; 270(9): 4551 - 4557.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1992 by the American Society for Biochemistry and Molecular Biology.